KYMR
#941
Kymera Therapeutics, Inc. - Common Stock
109.3 2 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.46%
Changement Mensuel
-5.76%
Evolution sur 6 mois
+22.76%
Changement Annuel
+84.97%
Clôture Précédente
112.0 8
Open
110.8 3
Low
109.2 0
High
112.0 0
Financials
- Market Capitalization 9.09 B
- Employee 273
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-21.09
ratio cours/chiffre d'affaires
167.66
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 914 |  KRYS Krystal Biotech, Inc. - Common Stock | 323.64 USD | -2.54% | -2.12% | -7.73% | +72.95% | 9.58 B USD | ||
| 938 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 141.08 USD | -2.62% | +1.18% | -5.90% | +87.78% | 9.13 B USD | ||
| 966 |  CYTK Cytokinetics, Incorporated - Common Stock | 62.46 USD | -0.53% | +0.92% | -15.03% | +7.50% | 8.68 B USD | ||
| 976 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 158.62 USD | -4.45% | -9.87% | -28.53% | +21.83% | 8.31 B USD |